Clinical Trials Browser

Phase 2 × Weight Loss × Gastrointestinal × Clear all

NCT05705492 2026-01-21

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

Phase 2 Recruiting

Gastrointestinal

Anorexia, Cachexia, Esophageal Neoplasms, Neoplasms, Colorectal Neoplasms, Weight Loss

NCT06937177 2025-12-12

Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy

Phase 2 Recruiting

Gastrointestinal

Cachexia, Colorectal Neoplasms, Weight Loss

NCT04844970 2025-11-17

Anamorelin Study for Advanced Pancreatic Cancer

Phase 2 Terminated

4 enrolled 12 charts

Gastrointestinal

Anorexia, Cachexia, Pancreatic Neoplasms, Weight Loss

NCT05546476 2025-05-31

PROACC-1

Phase 2 Completed

187 enrolled 24 charts

GastrointestinalThoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT04871204 2024-10-31

OTIS

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms, Weight Loss

NCT00196885 2008-06-20

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

Phase 2 Completed

GastrointestinalLymphoid

Carcinoma, Bronchogenic, Gastrointestinal Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Muscular Atrophy, Weight Loss